Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: A Randomized Double-blind Placebo-controlled Trial

NCT00371501 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT00371501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00371501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: A Randomized Double-blind Placebo-controlled Trial
Lead sponsor
Tuen Mun Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
December 31, 2009
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, systemic lupus erythematosus, thromboembolism